http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000229855-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0093c053cd8e072816de4d804a54542b
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
filingDate 1999-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecdcdce4b11f0fa766c181c3a9a33e94
publicationDate 2000-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2000229855-A
titleOfInvention Pravastatin sodium tablets
abstract (57) [Summary] [PROBLEMS] To prevent deterioration of the active ingredient pravastatin sodium in a tablet due to conversion into a lactone form. SOLUTION: Neutral to pH 9 as excipients for tablets A pravastatin sodium tablet is prepared by a conventional method using a substance that is less than. Preferably, a substance having a buffering or antacid action is used as part of the excipient. In addition, tablets obtained by tableting by a direct method based on mannitol not only can prevent changes to lactone bodies, Does not delay disintegration and elution times.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003055217-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006036781-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100514590-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03063836-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0197800-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010533210-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011049122-A1
priorityDate 1998-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395299
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084116
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393956
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448897384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66661409
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16759173
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66577512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453678473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226682284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425659704
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411126169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251

Total number of triples: 51.